A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

ClinicalTrials.gov ID: NCT06887192

Public ClinicalTrials.gov record NCT06887192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 3, 2026, 2:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis

Study identification

NCT ID: NCT06887192
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: MapLight Therapeutics; Industry
Enrollment: 300 participants

Conditions and interventions

Conditions

Psychosis Associated With Alzheimer's Disease

Interventions

ML-007C-MA Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 55 Years to 90 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 14, 2025
Primary completion: Nov 30, 2027
Completion: Nov 30, 2027
Last update posted: Mar 8, 2026

2025 – 2027

United States locations

U.S. sites: 22
U.S. states: 6
U.S. cities: 18

Facility	City	State	ZIP	Site status
Clinical Site	Phoenix	Arizona	85004	Recruiting
Clinical Site	Scottsdale	Arizona	85253	Recruiting
Clinical Site	Tucson	Arizona	85704	Recruiting
Clinical Site	Anaheim	California	92805	Recruiting
Clinical Site	Orange	California	92866	Recruiting
Clinical Site	San Diego	California	92123	Recruiting
Clinical Site	Boca Raton	Florida	33428	Recruiting
Clinical Site	Deerfield Beach	Florida	33442	Recruiting
Clinical Site	Doral	Florida	33122	Recruiting
Clinical Site	Homestead	Florida	33033	Recruiting
Clinical Site	Miami	Florida	33122	Recruiting
Clinical Site	Miami	Florida	33155	Recruiting
Clinical Site	Miami	Florida	33173	Recruiting
Clinical Site	Miami	Florida	33186	Recruiting
Clinical Site	Miami Gardens	Florida	33014	Recruiting
Clinical Site	Miami Gardens	Florida	33104	Recruiting
Clinical Site	Naples	Florida	34105	Recruiting
Clinical Site	Orlando	Florida	32807	Recruiting
Clinical Site	West Palm Beach	Florida	33407	Recruiting
Clinical Site	Las Vegas	Nevada	89121	Recruiting
Clinical Site	West Long Branch	New Jersey	07764	Recruiting
Clinical Site	Independence	Ohio	44131	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06887192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 8, 2026 · Synced May 3, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06887192 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →